NanoViricides Inc. (NNVC)

[drkazmd65]

We are being asked to accept that once the platform is proven to work, it can be customized to work for any virus. Therefore, we should likely accept that if it doesn't work for one virus, it likely will not work for any others.

However - we already have considerable evidence that the system (in a general sense) already works in animal models for Flucide and according to what Dr. Harris's group has done, with Dengue.

No - it has NOT YET been proven to work in Humans. Yes - the company still has to demonsrate that there is very little toxicity in the system (in general).

But the concept that forms the base platform has already been 'proven' (as much as anything is proven in science) to work across different viral systems.

And I don't think that the company has claimed that the method will work on 'all' viruses. Most types - as long as a ligand target for that virus can be identified and modeled - should be targetable using the platform though.

I will agree that - because of the Ebola angle - more eyes than usual will be watching what happens in the upcoming trials with Ebolacide2,.... so the impact (at least short-term) could potentially be large.

Conversely - IF the new Ebolacide2 formulation(s) do work I think it will be a lot better for NNVC than most here imagine. A demonstrated effectiveness in this formulation in the hands of our BSL4 equipped partners' labs against Ebola model animals could (indeed) put a fast-track on Ebolacide that would not be possible with Flucide still needing to get TOX testing done, the IND together & approved, and the human testing done.

The Ebolacide fast-track (if that happens) could get NNVC on the map and generating revenue a year or more earlier that would the long slog to get Flucide through it's hoops.